Trial
NCT04526912
Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Viela Bio
Collaborators
—
Condition
Acute Lung Injury
Intervention
VIB7734
Why stopped
Study met predefined futility criteria for efficacy endpoints.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-17